Jason S. Miyares
Attorney General of Virginia

Image of the Virginia AG Seal

Commonwealth of Virginia
Office of the Attorney General

Mark Herring
Attorney General

202 North Ninth Street
Richmond, Virginia 23219


For media inquiries only, contact:  
Charlotte Gomer, Press Secretary
Phone: (804)786-1022 
Mobile: (804) 512-2552
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


~ The General Assembly has passed Herring's&nbps;legislation that will help ensure that funds from opioid litigation are used for opioid abuse prevention, treatment and recovery ~

RICHMOND – Attorney General Mark R. Herring's legislation that will direct funds secured through his ongoing lawsuits against drug manufacturers and distributors toward opioid abuse prevention, treatment, and recovery, ensuring that the most money possible goes to actually address the opioid crisis, is headed to the Governor's desk to be signed into law. House Majority Leader Charniele Herring (HB2322) and Senator George Barker (SB1469) carried Attorney General Herring's legislation in the House and Senate.


This legislation will make Virginia one of the first states in the nation to have a legislatively enacted framework for directing funds from opioid litigation, like the $13 million Attorney General Herring recently secured through a settlement with McKinsey and Company for its role in "turbocharging” the opioid crisis, towards opioid abatement, treatment, and recovery, instead of diverting it to other uses.


"I have made it a top priority during my time as attorney general to hold those responsible for creating, prolonging, and profiting off the opioid crisis accountable,” said Attorney General Herring. "This crisis has turned lives upside-down and devastated families and communities in every corner of our Commonwealth. This authority will ensure that, should I be successful in taking on these companies, a majority of the funds go towards addressing the crisis, expanding treatment and recovery, and saving Virginians. I want to thank Majority Leader Herring, Senator Barker, and the many advocates who worked with us to strengthen and pass this important legislation.”


"Attorney General Herring has worked hard to hold big drug companies accountable for the role that they played in creating and profiting off the ongoing opioid crisis,” said Majority Leader Herring. "This legislation is such an important step in ensuring that structures are created for using abatement money the Attorney General is able to secure goes back to our communities to do the most good as quickly as possible. It is so important that we use this money to expand Virginia's capacity for opioid use disorder treatment and recovery programs, and to help us turn this crisis around.”


"This opioid abatement authority will be an effective approach to handling money that could come from Attorney General Herring's work against these pharmaceutical companies who, in many ways, really created this opioid crisis,” said Senator Barker. "With this new authority, Virginia will be a leader in the national movement to hold these drug manufacturers accountable and we can ensure that any judgements or settlements go to where they are needed most – back into our communities.”


"This is an important step in our work to combat the opioid crisis here in Virginia, but there is more that we still need to do and it will be incredibly important to involve the recovery community in every step of that process,” said John Shinholser, President of the McShin Foundation, a Richmond area recovery community and a prominent leader in the fight against substance use disorder. "Attorney General Herring has been a true friend to the recovery community, and a reliable partner in identifying and supporting ideas, laws, and programs that will actually save lives and help people enter long term recovery.”


SB1469 and HB2322 from Attorney General Herring, Senator Barker, and Majority Leader Herring will create a structure and framework for ensuring that "opioid abatement” funds recovered as part of AG Herring's ongoing lawsuits and investigations against opioid manufacturers and distributors are used to fund opioid abuse prevention, treatment, and recovery. It will help bring order and predictability to the distribution process if funds are secured, rather than forcing the Commonwealth to wait for a potentially significant influx of money, and then having to decide how to handle it.


The bill will establish an Opioid Abatement Authority controlled by subject matter experts who will ensure that funds are used wisely to support prevention, treatment, and recovery. The Board of the Opioid Abatement Authority will include:


  1. The Secretary of Health & Human Resources or their designee
  2. Two medical professionals with expertise in public and behavioral health administration or opioid use disorders and their treatment
  3. A representative of the addiction and recovery community
  4. An urban or suburban representative from a CSB
  5. A rural representative from a CSB
  6. A law enforcement official
  7. A local government official
  8. A local government attorney
  9. Chair of the Senate Committee on Finance and Appropriations or their designee and the Chari of the House Appropriations Committee on Appropriations or their designee


The legislation calls for the abatement funds to be partitioned in the following way:

  • 70% for opioid abatement split evenly (35% each) between 1) regional projects and 2) projects identified as effective by the Board of experts.
  • 15% reserved for state-identified abatement initiatives
  • 15% reserved for locality-identified abatement initiatives


The opioid crisis has been one of Attorney General Herring's top priorities, and as part of this work he has focused on accountability for pharmaceutical manufacturers and distributors who helped create, prolong, and profit from the opioid crisis in Virginia and around the country. Attorney General Herring has filed suit against Purdue Pharma; the Sackler Family, owners of Purdue Pharma; and Teva/Cephalon for the roles that they played in creating the opioid epidemic. Additional multistate investigations and legal actions remain ongoing.


# # #